U.S. Cannabinoids Market Regional Outlook, Development Strategy and Forecast 2027

U.S. Cannabinoids Market size was valued at US$ 4.5 Mn. in 2020 and the total revenue is expected to grow at 20.4 % through 2021 to 2027, reaching nearly US$ 16.4 Mn.

U.S. Cannabinoids Market Overview:

The "Global U.S. Cannabinoids Market Analysis" is a specialized and extensive examination of the U.S. Cannabinoids market, with a particular emphasis on global market trends and analysis. The purpose of this study is to give an overview of the U.S. Cannabinoids market, as well as extensive market segmentation by segments, and geography. During the projected period, the U.S. Cannabinoids market is anticipated to grow rapidly. The research provides important information on the market position of the main U.S. Cannabinoids major players, as well as significant market trends and opportunities.

Market Scope:

Top-down and bottom-up approaches are used to validate the market size and to estimate the market size by different segments. The market estimations in the report are based on the sale price (excluding any discounts provided by the manufacturer, distributor, wholesaler, or traders). The percentage splits, market shares, and breakdowns of the segments are derived based on weights assigned to each of the segments on their utilization rate and average sale price. The country-wise splits of the overall market and its sub-segments are based on the percentage adoption or utilization of the given market Size in the respective region or country.

Get a Sample PDF: https://www.maximizemarketresearch.com/request-sample/124261 

Segmentation:

In 2019, the CBD category dominated the US cannabinoid market, accounting for 69.1 percent of total sales. This high percentage is due to an increasing number of consumers selecting isolated cannabis products and increased knowledge of cannabinoid products for health and wellbeing in the United States. The legalization of cannabis-based goods has given the end-user industries tre4mendous potential to grow. The overall growth is likely to be aided by an increase in research activities, increased awareness of synthetic CBD, and increased strategic expenditures by businesses during the forecast period.

Key Players:

• Mile High Labs International
• Global Cannabinoids
• GenCanna
• CBD, Inc. Group
• SparkCBD
• Rhozo Sciences
• Maricann, Inc.
• Jsuhi Holdings Inc.
• Columbia Care
• Verano Holding
• Holistic Industry
• Cannalysis
• Demetrix
• The Valens Company
• Eaze
• Treez Inc.
• Cresco Labs.

Secondary research is used to identify market leaders, while primary and secondary research is used to establish market revenue. Secondary research comprised a review of the leading manufacturers' annual and financial reports, whilst primary research included thorough interviews with key opinion leaders and industry specialists such as experienced front-line personnel, CEOs, and marketing executives. Secondary sources are used to calculate percentage splits, market shares, growth rates, and worldwide market breakdowns, which are then validated using primary sources. The following is a list of a few firms involved in the U.S. Cannabinoids industry.

Regional Analysis:

The U.S. Cannabinoids research details the geographic analysis, which is further broken into sub-regions and countries. This section of the report contains information on profit forecasts as well as market share in each country. This part of the study discusses each region's and country's share and growth rate over the estimated time.

The report also provides a decisive PESTEL analysis for all five regions namely; North America, Europe, Asia Pacific, Middle East, Africa, and South America after evaluating political, economic, social, and technical factors affecting the U.S. Cannabinoids market in these regions.

COVID-19 Impact Analysis on U.S. Cannabinoids Market:

Customer behavior has shifted across all areas of society as a result of the COVID-19 outbreak. Industries, on the other hand, will need to modify their strategy to adapt to shifting market supply. This research provides an overview of the COVID-19 influence on the U.S. Cannabinoids market and will assist you in developing your company in accordance with the new industry standards.

Under the COVID-19 Impact section, the U.S. Cannabinoids Market Report provides a 360-degree analysis ranging from the flexible supply chain, and import control, to provincial government policy and future influence on the company. Primary research on the market situation (2021-2027), venture rivalry example, advantages, and disadvantages of large business streams, and industry development patterns (2021-2027), have all been included

Key Questions Answered in the U.S. Cannabinoids Market Report are:

• What is the market potential for U.S. Cannabinoids?

• Which regional market will emerge as a leader in the next years?

• Which application category will see rapid growth 

• What chances for development could exist in the U.S. Cannabinoids sector in the upcoming years 

• What are the most important future obstacles that the U.S. Cannabinoids market may face?

• Who are the market leaders in the U.S. Cannabinoids segment?

• What are the primary trends that are positively affecting market growth?

Contact us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT Park Phase 2,

Pune Banglore Highway,

Narhe, Pune, Maharashtra 411041, India.

Email: sales@maximizemarketresearch.com

Phone No.: +91 9607365656

Website: www.maximizemarketresearch.com